chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Insomnia, Pain, Pruritus, Vaccination site erythema
Clinical narrative: It was so bad that he could hardly sleep; warm; night the area started itching; It's a large red circle around the injection site; it was just a little bit sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (It's a large red circle around the injection site), PAIN (it was just a little bit sore), PRURITUS (night the area started itching), INSOMNIA (It was so bad that he could hardly sleep) and FEELING HOT (warm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 immunisation.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN (it was just a little bit sore). On 05-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (It's a large red circle around the injection site). On 08-Feb-2021, the patient experienced PRURITUS (night the area started itching). On 09-Feb-2021, the patient experienced INSOMNIA (It was so bad that he could hardly sleep) and FEELING HOT (warm). At the time of the report, VACCINATION SITE ERYTHEMA (It's a large red circle around the injection site), PAIN (it was just a little bit sore), PRURITUS (night the area started itching), INSOMNIA (It was so bad that he could hardly sleep) and FEELING HOT (warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were not provided. Treatment details Ice,Mosquito bite medication,Topical antihistamine
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: chills; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and FATIGUE (felt tired) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced CHILLS (chills) and FATIGUE (felt tired). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 31-Jan-2021, CHILLS (chills) and FATIGUE (felt tired) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 69.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Blood glucose abnormal, Chills, Fatigue, Headache
Clinical narrative: muscle pain; joint pain; nausea; banging headache; fever; soaring blood sugar; chills; sweating; tired; horrible pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (banging headache) and PYREXIA (fever) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (banging headache), PYREXIA (fever), BLOOD GLUCOSE ABNORMAL (soaring blood sugar), CHILLS (chills), HYPERHIDROSIS (sweating), FATIGUE (tired) and PAIN (horrible pain). At the time of the report, MYALGIA (muscle pain), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (banging headache), PYREXIA (fever), BLOOD GLUCOSE ABNORMAL (soaring blood sugar), CHILLS (chills), HYPERHIDROSIS (sweating), FATIGUE (tired) and PAIN (horrible pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided
Age: 69.0
Sex: U
Vaccine: COVID19
Symptoms: Hyperhidrosis, Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: muscle pain; joint pain; nausea; banging headache; fever; soaring blood sugar; chills; sweating; tired; horrible pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (banging headache) and PYREXIA (fever) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (banging headache), PYREXIA (fever), BLOOD GLUCOSE ABNORMAL (soaring blood sugar), CHILLS (chills), HYPERHIDROSIS (sweating), FATIGUE (tired) and PAIN (horrible pain). At the time of the report, MYALGIA (muscle pain), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (banging headache), PYREXIA (fever), BLOOD GLUCOSE ABNORMAL (soaring blood sugar), CHILLS (chills), HYPERHIDROSIS (sweating), FATIGUE (tired) and PAIN (horrible pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pollakiuria, Pyrexia
Clinical narrative: peeing every 2 hours; body aches; Chills; fever 99/100 °F; headache; sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (peeing every 2 hours), PAIN (body aches), CHILLS (Chills), PYREXIA (fever 99/100 °F) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chronic kidney disease stage 3.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced POLLAKIURIA (peeing every 2 hours), PAIN (body aches), CHILLS (Chills), PYREXIA (fever 99/100 °F), HEADACHE (headache) and VACCINATION SITE PAIN (sore at the injection site). At the time of the report, POLLAKIURIA (peeing every 2 hours), PAIN (body aches), CHILLS (Chills), PYREXIA (fever 99/100 °F), HEADACHE (headache) and VACCINATION SITE PAIN (sore at the injection site) outcome was unknown.            Concomitant medication Thyroids pills, Cholesterol pills, Blood pressure pills Treatment medications were not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: peeing every 2 hours; body aches; Chills; fever 99/100 °F; headache; sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (peeing every 2 hours), PAIN (body aches), CHILLS (Chills), PYREXIA (fever 99/100 °F) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chronic kidney disease stage 3.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced POLLAKIURIA (peeing every 2 hours), PAIN (body aches), CHILLS (Chills), PYREXIA (fever 99/100 °F), HEADACHE (headache) and VACCINATION SITE PAIN (sore at the injection site). At the time of the report, POLLAKIURIA (peeing every 2 hours), PAIN (body aches), CHILLS (Chills), PYREXIA (fever 99/100 °F), HEADACHE (headache) and VACCINATION SITE PAIN (sore at the injection site) outcome was unknown.            Concomitant medication Thyroids pills, Cholesterol pills, Blood pressure pills Treatment medications were not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pruritus
Clinical narrative: Itches; Redness; Aches; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itches), ERYTHEMA (Redness) and PAIN (Aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PRURITUS (Itches), ERYTHEMA (Redness) and PAIN (Aches). At the time of the report, PRURITUS (Itches), ERYTHEMA (Redness) and PAIN (Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vaccination site erythema, Vaccination site warmth
Clinical narrative: Dizziness; Red and warm at the injection site; Red and warm at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), VACCINATION SITE WARMTH (Red and warm at the injection site) and VACCINATION SITE ERYTHEMA (Red and warm at the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL and AMLODIPINE for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced DIZZINESS (Dizziness), VACCINATION SITE WARMTH (Red and warm at the injection site) and VACCINATION SITE ERYTHEMA (Red and warm at the injection site). The patient was treated with HYDROCORTISONE for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), VACCINATION SITE WARMTH (Red and warm at the injection site) and VACCINATION SITE ERYTHEMA (Red and warm at the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications Lisinopril, Amlodipine.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Headache, Pyrexia, SARS-CoV-2 test
Clinical narrative: Mild coughing; Headaches here and there; Fever 101.6-103; This spontaneous case was reported by a nurse and describes the occurrence of COUGH (Mild coughing), PYREXIA (Fever 101.6-103) and HEADACHE (Headaches here and there) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Systemic lupus erythematosus.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jan-2021, the patient experienced PYREXIA (Fever 101.6-103). On 26-Jan-2021, the patient experienced COUGH (Mild coughing) and HEADACHE (Headaches here and there). At the time of the report, COUGH (Mild coughing), PYREXIA (Fever 101.6-103) and HEADACHE (Headaches here and there) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, Body temperature: 101.6-103.2 High. On 26-Jan-2021, SARS-CoV-2 test: positive Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications and treatment medications were reported.   This case was linked to MOD-2021-029547 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: Rash for a few days/Covid arm; Painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Painful) and VACCINATION SITE RASH (Rash for a few days/Covid arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 629K20A) for COVID-19 vaccination.     The patient's past medical history included Breast implant rupture, Itching and Fibromyalgia. Concomitant products included SIMVASTATIN and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (Painful). On 05-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash for a few days/Covid arm). At the time of the report, VACCINATION SITE PAIN (Painful) had not resolved and VACCINATION SITE RASH (Rash for a few days/Covid arm) had resolved.            No treatment information was provided.  Patient took second dose on 22 Feb 2021.   This case was linked to MOD-2021-239042 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Ethnic group was updated. Medical history added. Concomitant medication were added. Vaccine facility name, covid vaccine second dose details were updated.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Looks like it is spreading; hard; itchy where the shot was given; it is very red; Swollen; very painful; A spontaneous report was received from a nurse concerning a 47 years old female patient who received Moderna (mRNA-1273) vaccine and  arm became  red, swollen, itchy, painful, hard and looked like spreading.  The patient's medical history was not provided.  Products known to have been used by the patient, within two weeks prior to the event, included lorazepam.  On 1 Feb 2021, prior to the onset of symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 007M20A) intramuscularly in her right arm for prophylaxis of Covid-19 infection . On 8 Feb 2021, one week after receiving the vaccine, the vaccination site was red, swollen, itchy, and painful. The area was still  very hard, swollen, and very red. It looked like it was spreading. No lab data was provided.Treatment information included Allegra   Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events red, swollen, itchy, painful, hard and looked like spreading were not recovered.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Looks like it is spreading; hard; itchy where the shot was given; it is very red; Swollen; very painful; A spontaneous report was received from a nurse concerning a 47 years old female patient who received Moderna (mRNA-1273) vaccine and  arm became  red, swollen, itchy, painful, hard and looked like spreading.  The patient's medical history was not provided.  Products known to have been used by the patient, within two weeks prior to the event, included lorazepam.  On 1 Feb 2021, prior to the onset of symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 007M20A) intramuscularly in her right arm for prophylaxis of Covid-19 infection . On 8 Feb 2021, one week after receiving the vaccine, the vaccination site was red, swollen, itchy, and painful. The area was still  very hard, swollen, and very red. It looked like it was spreading. No lab data was provided.Treatment information included Allegra   Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events red, swollen, itchy, painful, hard and looked like spreading were not recovered.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash
Clinical narrative: bad itching; big red rash on their arm; sore arm; A spontaneous report was received from a consumer concerning, a male patient of an unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a sore arm/pain in extremity, had a bad itching /pruritus and a huge red oblong circle, pretty large, like 3x4 inches.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 28 Jan 2021, prior to the onset of the events, the patient received their first of the two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route in the left arm for prophylaxis of COVID-19 infection.   On an unknown day post receiving the vaccine, the patient had a sore arm for a day and a half. Seven days later the patient woke up in the middle of the night with a bad itching, and had a huge red oblong circle, pretty large, like 3x4 inches. The patient had their redness gone but still had itching.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the event(s) was not reported.  The outcome of the events a sore arm, a huge red oblong circle, pretty large, like 3x4 inches were resolved at the time of this report and the outcome of the event had a bad itching was not resolved at the time of this report.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Injection site pain, Myalgia
Clinical narrative: muscle aches; pain at injection site; fever; Chills; Headache; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jan-2021. The most recent information was received on 08-Jul-2021 and was forwarded to Moderna on 08-Jul-2021.     This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (Chills), HEADACHE (Headache), MYALGIA (muscle aches) and INJECTION SITE PAIN (pain at injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011j20a) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 25-Jan-2021 at 10:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On 25-Jan-2021 at 10:00 PM, the patient experienced PYREXIA (fever), CHILLS (Chills) and HEADACHE (Headache). On 26-Jan-2021 at 1:00 AM, the patient experienced MYALGIA (muscle aches) and INJECTION SITE PAIN (pain at injection site).   The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency.   On 26-Jan-2021 at 8:00 AM, PYREXIA (fever), CHILLS (Chills) and HEADACHE (Headache) had resolved.   On 26-Jan-2021 at 9:00 PM, MYALGIA (muscle aches) and INJECTION SITE PAIN (pain at injection site) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Body temperature: 102 (High) Patient had a fever of 102 F.   Concomitant product use was not provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Causality as Reported Source updated for events.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: muscle aches; pain at injection site; fever; Chills; Headache; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jan-2021. The most recent information was received on 08-Jul-2021 and was forwarded to Moderna on 08-Jul-2021.     This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (Chills), HEADACHE (Headache), MYALGIA (muscle aches) and INJECTION SITE PAIN (pain at injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011j20a) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 25-Jan-2021 at 10:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On 25-Jan-2021 at 10:00 PM, the patient experienced PYREXIA (fever), CHILLS (Chills) and HEADACHE (Headache). On 26-Jan-2021 at 1:00 AM, the patient experienced MYALGIA (muscle aches) and INJECTION SITE PAIN (pain at injection site).   The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency.   On 26-Jan-2021 at 8:00 AM, PYREXIA (fever), CHILLS (Chills) and HEADACHE (Headache) had resolved.   On 26-Jan-2021 at 9:00 PM, MYALGIA (muscle aches) and INJECTION SITE PAIN (pain at injection site) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Body temperature: 102 (High) Patient had a fever of 102 F.   Concomitant product use was not provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Causality as Reported Source updated for events.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Pain
Clinical narrative: Arm soreness; Achiness; Joint pain; Muscle pain; Fever; Headache; Chills; Achiness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), the first episode of PAIN (Achiness), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), the first episode of PAIN (Achiness), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and the second episode of PAIN (Achiness). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm soreness), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and the last episode of PAIN (Achiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Arm soreness; Achiness; Joint pain; Muscle pain; Fever; Headache; Chills; Achiness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), the first episode of PAIN (Achiness), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), the first episode of PAIN (Achiness), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and the second episode of PAIN (Achiness). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm soreness), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and the last episode of PAIN (Achiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: fever; Pain at injection site; fatigue; A spontaneous report was received from a consumer concerning a 73-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain at injection site, fatigue, fever.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 039K20A) intramuscularly for prophylaxis of COVID-19 infection. On unknown date, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 028120A) intramuscularly for prophylaxis of COVID-19 infection.  On 9 Feb 2021, the patient experienced the event(s) pain at injection site, fatigue, fever.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), pain at injection site, fatigue, fever was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: headache; nauseas; A spontaneous report was received from a consumer concerning a 74-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced headache and nausea.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 011J20A) via unknown route for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced headache and felt nauseas.  Treatment details was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (Pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain). At the time of the report, PAIN (Pain) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: severe arm pain; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe arm pain) and PAIN (soreness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis, Blood pressure high, Diabetes and Joint ache.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (severe arm pain) and PAIN (soreness). At the time of the report, PAIN IN EXTREMITY (severe arm pain) and PAIN (soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included medications for rheumatoid arthritis, high blood pressure, diabetes and joint pains.  No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sneezing, Wheezing
Clinical narrative: mild whizzing; nose running; sneezing; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (mild whizzing), RHINORRHOEA (nose running) and SNEEZING (sneezing) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021 at 5:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced RHINORRHOEA (nose running) and SNEEZING (sneezing). On 09-Feb-2021, the patient experienced WHEEZING (mild whizzing). The patient was treated with FEXOFENADINE HYDROCHLORIDE at a dose of 180 mg. At the time of the report, WHEEZING (mild whizzing), RHINORRHOEA (nose running) and SNEEZING (sneezing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Feeling abnormal, Headache, Pain
Clinical narrative: "Foggy Headiness; Trouble with word recall; experience a headache; soreness; A spontaneous report was received from a consumer concerning a 71-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events soreness,/general body pain, headache, foggy headiness/feeling abnormal, trouble with word recall/aphasia.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 8 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 8 Feb 2021, the patient experienced the event(s) soreness, headache, foggy headiness, trouble with word recall.  Treatment details included Ibuprofen, Electrolytes.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), soreness, headache, foggy headiness, trouble with word recall,  was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza like illness
Clinical narrative: Body cut with flu-like symptoms; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Body cut with flu-like symptoms) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Body cut with flu-like symptoms) and HEADACHE (Headache). At the time of the report, INFLUENZA LIKE ILLNESS (Body cut with flu-like symptoms) and HEADACHE (Headache) outcome was unknown.            Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Feeling abnormal, Feeling of relaxation
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (pretty bad joint pain and eye lid twitching), MALAISE (felt not great), PAIN (today is really hurting), FEELING ABNORMAL (doesn't feel good today either) and FEELING OF RELAXATION (felt a little bit better on Saturday) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included MS since 2016. Concomitant products included GLATIRAMER ACETATE (COPAXONE) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced MALAISE (felt not great) and FATIGUE (fatigue). On 28-Jan-2021, the patient experienced ARTHRALGIA (pretty bad joint pain and eye lid twitching) and CHILLS (chills). On 06-Feb-2021, the patient experienced FEELING OF RELAXATION (felt a little bit better on Saturday). On 08-Feb-2021, the patient experienced PAIN (today is really hurting). On 09-Feb-2021, the patient experienced FEELING ABNORMAL (doesn't feel good today either). On an unknown date, the patient experienced MUSCLE TWITCHING (pretty bad joint pain and eye lid twitching). At the time of the report, MUSCLE TWITCHING (pretty bad joint pain and eye lid twitching), MALAISE (felt not great), PAIN (today is really hurting), FEELING ABNORMAL (doesn't feel good today either), FEELING OF RELAXATION (felt a little bit better on Saturday), ARTHRALGIA (pretty bad joint pain and eye lid twitching), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products also included immunomodulator and muscle relaxants for an unknown indication.  Treatment for the event included nonsteroidal anti-inflammatory drugs (NSAIDs).
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Muscle twitching, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (pretty bad joint pain and eye lid twitching), MALAISE (felt not great), PAIN (today is really hurting), FEELING ABNORMAL (doesn't feel good today either) and FEELING OF RELAXATION (felt a little bit better on Saturday) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included MS since 2016. Concomitant products included GLATIRAMER ACETATE (COPAXONE) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced MALAISE (felt not great) and FATIGUE (fatigue). On 28-Jan-2021, the patient experienced ARTHRALGIA (pretty bad joint pain and eye lid twitching) and CHILLS (chills). On 06-Feb-2021, the patient experienced FEELING OF RELAXATION (felt a little bit better on Saturday). On 08-Feb-2021, the patient experienced PAIN (today is really hurting). On 09-Feb-2021, the patient experienced FEELING ABNORMAL (doesn't feel good today either). On an unknown date, the patient experienced MUSCLE TWITCHING (pretty bad joint pain and eye lid twitching). At the time of the report, MUSCLE TWITCHING (pretty bad joint pain and eye lid twitching), MALAISE (felt not great), PAIN (today is really hurting), FEELING ABNORMAL (doesn't feel good today either), FEELING OF RELAXATION (felt a little bit better on Saturday), ARTHRALGIA (pretty bad joint pain and eye lid twitching), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products also included immunomodulator and muscle relaxants for an unknown indication.  Treatment for the event included nonsteroidal anti-inflammatory drugs (NSAIDs).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Nausea, Pyrexia, Vomiting
Clinical narrative: Temperature of 101.9 the entire day; Nausea; Vomiting and couldn't keep liquids down; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting and couldn't keep liquids down), HEADACHE (Headache) and PYREXIA (Temperature of 101.9 the entire day) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced NAUSEA (Nausea), VOMITING (Vomiting and couldn't keep liquids down) and HEADACHE (Headache). On 06-Feb-2021, the patient experienced PYREXIA (Temperature of 101.9 the entire day). On 07-Feb-2021, NAUSEA (Nausea), VOMITING (Vomiting and couldn't keep liquids down), HEADACHE (Headache) and PYREXIA (Temperature of 101.9 the entire day) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, Body temperature: 101.9 101.9.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitent medication provided Treatment inciuded  ibuprofen and Tylenol   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up received on 22-apr-2021,NNI
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Myalgia, Pain in extremity
Clinical narrative: stiffness in leg/stiffness has spread to the knee and calf; achiness has spread to the knee and calf; achiness in leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (achiness in leg), MUSCULOSKELETAL STIFFNESS (stiffness in leg/stiffness has spread to the knee and calf) and MYALGIA (achiness has spread to the knee and calf) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (achiness in leg). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (stiffness in leg/stiffness has spread to the knee and calf) and MYALGIA (achiness has spread to the knee and calf). At the time of the report, PAIN IN EXTREMITY (achiness in leg), MUSCULOSKELETAL STIFFNESS (stiffness in leg/stiffness has spread to the knee and calf) and MYALGIA (achiness has spread to the knee and calf) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Herpes zoster, Hypokinesia, Migraine, Rash
Clinical narrative: Migraine; shingles; could not eat; Could not stand a few days after vaccine; rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (Migraine), HERPES ZOSTER (shingles), FEEDING DISORDER (could not eat), HYPOKINESIA (Could not stand a few days after vaccine) and RASH (rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine), HERPES ZOSTER (shingles), FEEDING DISORDER (could not eat), HYPOKINESIA (Could not stand a few days after vaccine) and RASH (rash). At the time of the report, MIGRAINE (Migraine), HERPES ZOSTER (shingles), FEEDING DISORDER (could not eat), HYPOKINESIA (Could not stand a few days after vaccine) and RASH (rash) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Herpes zoster: diagnosed with shingles on 2 or 3 Feb 2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity
Clinical narrative: Numbness facial; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness facial) and PAIN IN EXTREMITY (Pain in arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039k20a and 010mz0a) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (Shrimp).   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness facial) and PAIN IN EXTREMITY (Pain in arm). On 22-Jan-2021, HYPOAESTHESIA (Numbness facial) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain in arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications were reported as none.  The patient reported her cheek numbness was gone within an hour or two but every now and then over the next week, it would feel numb again like she had Novocain. The patient also reported she had her second dose of vaccine and her cheek never went numb. She reported she had a sore arm with both shots.   No treatment information was provided.  The reporter did not provide the causality assessment for the event with regards to mRNA-1273.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow up report included: Allergy, adverse event start date and stop date, new Dose 1 event, vaccine information for Dose 1 and Dose 2 and Dose 2 event.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure fluctuation, Headache, Nausea, Pyrexia
Clinical narrative: Fever; Nausea; Headaches; Elevated Blood Pressure; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headaches) and BLOOD PRESSURE FLUCTUATION (Elevated Blood Pressure) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headaches) and BLOOD PRESSURE FLUCTUATION (Elevated Blood Pressure). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headaches) and BLOOD PRESSURE FLUCTUATION (Elevated Blood Pressure) outcome was unknown.            No relevant concomitant medications were reported.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Dizzness; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzness), NAUSEA (nausea) and VOMITING (vomiting) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzness), NAUSEA (nausea) and VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzness), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore left arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol, Blood pressure and Heart rate high. Concomitant products included CALCIUM, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and COLECALCIFEROL (VIT D3) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore left arm). On 17-Jan-2021, VACCINATION SITE PAIN (sore left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications reported also included cholesterol medication, blood pressure medication and medication for fast heart beat.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Fever; Headache; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown. Not Provided           No relevant concomitant medications were reported.